Selpercatinib, Potent and selective RET kinase inhibitor (TBI4407)

Description

Product Details

Formal Name: 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methyoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridine-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

Alternate Names: LOXO-292

Molecular Formula: C₂₉H₃₁N₇O₃

Formula Weight: 525.6

CAS Number: 2152628-33-4

Purity: >98%

Formulation: Powder

Solubility: Soluble in DMSO (up to 10 mg/ml).

Storage: -20°C

Stability: ≥ 2 years.

Applications

Potent and selective RET kinase inhibitor

Functions

Potent (IC₅₀ = 0.45 nM) and selective inhibitor of RET kinase. Clinically relevant for the treatment of RET-altered non-small cell lung cancer and certain thyroid cancers.

Application Procedures

First dissolved in DMSO (10 mg/ml), then diluted to aqueous buffer. Solutions in DMSO may be stored at -20°C for up to 3 months.

Research use only.

Additional information

Datasheet:

TBI4407_Selpercatinib_datasheet

MSDS:

TBI4407_Selpercatinib_MSDS_2024

Research use only.